Abstract 342P
Background
This study aimed to assess breast cancer (BC) patients' knowledge and perception of fertility risks and preservation, and to determine factors that impact fertility preservation(FP) patient decision making.
Methods
We performed a cross-sectional study including 70 BC patients ≤ 45 year-old. Patients were surveyed using a 29 item questionnaire assessing their personal experience and knowledge about fertility risks and FP treatments. A knowledge score (0-12) was calculated with 1 point awarded for each correct answer. Statistical associations between socio-demographic characteristics, personal experience and knowledge score were analyzed.
Results
Mean age was 34 year-old. Thirty-seven patients had a college degree and 80% were married. Previous pregnancy/live birth were reported in 77%/72% of patients. Twenty-seven percent of patients had prior contact with infertility. Fifty-five patients were informed about infertility risks related to BC treatment. Only 62.8% of patients received information about FP treatments. Thirty-five patients were referred to FP consultation of whom 12 patients received FP treatments. Embryos/oocytes freezing were the main used options. The main reasons for skipping FP treatments were lack of pregnancy desire (38.6%) and insufficient provided information (30%). “Complexity of FP procedure” and “fear of delaying cancer treatment” were reported in 8.6% and 4.3% of cases respectively. Mean knowledge score was 6(3 -11). Forty-six percent of patients believed that “FP treatment is related to an increased risk of cancer recurrence”. Only 61.4% of patients were aware that “freezed eggs remain available in the future whenever the patient is ready to use them”. Most of the patients (81.4%) were aware that having a spouse was not a prerequisite for FP treatment. Knowledge about FP treatments availability and costs was poor with more than half of patients overestimating costs and assuming the lack of FP treatment options. Only 60% of patients were aware of an operational legal framework for FP in Tunisia.
Conclusions
This study showed that FP baseline knowledge in BC patients is generally poor. Patient's access to clear and concise fertility information is the key for effective interventions for fertility preservation.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
350P - Quality of life data on sexual relations in early breast cancer patients
Presenter: María Garrido
Session: Poster session 03
351TiP - EORTC BCG 1984 – NOBLE: Noeoadjuvant olaparib and durvalumab for patients with BRCA-associated triple-negative breast cancer
Presenter: Emanuel Buhrer
Session: Poster session 03
352TiP - Neoadjuvant chemo-immunotherapy plus/minus fasting-like approach in stage II-III triple-negative breast cancer patients: The phase II randomized BREAKFAST-2 trial
Presenter: Claudio Vernieri
Session: Poster session 03
355P - Reduction of anthracycline use with a combined imaging and pathology prediction model in the neoadjuvant I-SPY2 trial
Presenter: Angela DeMichele
Session: Poster session 03
356P - Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
Presenter: Soumya Gottipati
Session: Poster session 03
357P - Prediction of pathologic response to neoadjuvant chemotherapy (NAC) using diffuse optical breast scanner (DOB-Scan) in patients with locally advanced breast cancer (LABC)
Presenter: Phuong Thao Nguyen
Session: Poster session 03
358P - Major adverse cardiovascular event outcomes of adjuvant taxane + anthracycline versus taxane-based chemotherapy in older adults with triple-negative breast cancer: A SEER-Medicare study
Presenter: Savannah Roy
Session: Poster session 03
359P - Unveiling the factors influencing exercise engagement in breast cancer patients: Insights from the early recovery phase
Presenter: Sujin Yeon
Session: Poster session 03